Pulling the latest in this topic…
C-suite moves, stocks, investments, M&A
2598 briefings briefings in Business
Mainland China investors and Hong Kong capital flows are recalibrating ahead of SpaceX’s likely record-breaking listing.
Internal planning materials point to FY2027 monetization for creators, shifting LinkedIn further from networking to a social feed.
Households with at least one GLP-1 user rose to 6.3% in Great Britain, reshaping grocery and pricing incentives.
A five-year-old startup just priced itself at $12 billion after a $600 million raise, and the signals are louder than they look.
Candy Kittens founder argues creators win with speed, authenticity, and acquisitions like Graze's £36m deal.
A $670,000-per-charger rollout is BYD’s fastest attempt yet to reshape European charging expectations.
Fortune’s conference panel ties U.S. timing risk to FDA reality, long timelines, and a global AI race.
The BBC is putting Doctor Who out to competitive tender, and Davies claims the “special” was never actually made.
London’s 01Health is turning the clinical platform behind its dental brands into infrastructure other practices can buy.
BYD says it can surpass Toyota by scaling battery advances, fast charging, and overseas production, starting with £1.8bn flash chargers in Europe.
Xi'an UniIC’s DRAM push joins CXMT to monetize China’s memory supercycle, with regulatory timing now front and center.
Libertarian-backed performance drugs meet FDA-only “protocols,” and the fight is really over norms.
